Intelligence · Patents

Patents expiring in 2030

Annual patent cliff calendar for 2030 — US pharmaceutical patents by expiration date.

Patents
880

Quick answer

880 indexed pharmaceutical patents have expiration dates in 2030. Browse by soonest expiry with links to assignee companies and related drugs.

  1. US 7846450

    Melanoma associated peptide analogues and vaccines against melanoma

    UNITED STATES OF AMERICA, AS REPRESENTED BY SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES · Granted Tue Dec 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. US 7846892

    Compositions and methods for Alzheimer's disease

    Primex Clinical Laboratories, Inc. · Granted Tue Dec 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  3. US 7846954

    Heterocyclic derivatives as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Tue Dec 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  4. US 7847084

    VMP-like sequences of pathogenic Borrelia species and strains

    The Board of Regents of the University of Texas System · Granted Tue Dec 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  5. US 7851631

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Tue Dec 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  6. US 7850961

    Methods for targeting solid tumor stem cells in a solid tumor using a notch4 receptor antagonist

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Dec 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  7. US 7850970

    Inhibitors of serine protease activity and their use in methods and compositions for treatment of bacterial infections

    The Regents of the University of Colorado · Granted Tue Dec 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  8. US 7851169

    Compositions and methods for inhibiting squamous cell carcinoma

    The United States of America as represented by the Department of Veterans Affairs Office of the General Counsel · Granted Tue Dec 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  9. US 7851445

    Angiogenic heparin-binding epitopes, peptide amphiphiles, self-assembled compositions and related methods of use

    Northwestern University · Granted Tue Dec 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  10. US 7851449

    Peptide, pharmaceutical composition, and a method of treating microcirculation disorders

    Obschestvo S Ogranichennoi Otvetstvennostyu “Sia Peptides” · Granted Tue Dec 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  11. US 7851465

    Compositions and methods relating to novel compounds and targets thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Dec 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  12. US 7851228

    Methods for screening agents that modulate presenilin activity and A-β production

    The Regents of the University of California · Granted Tue Dec 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  13. US 7851467

    Carbamate compounds as 5-HT4 receptor agonists

    Theravance, Inc. · Granted Tue Dec 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  14. US 7851473

    Amide compound

    Takeda Pharmaceutical Company Limited · Granted Tue Dec 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  15. US 7851480

    Spiro 2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Tue Dec 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  16. US 7851506

    Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy

    Jazz Pharmaceuticals, Inc. · Granted Tue Dec 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  17. US 7851565

    Stabilized polymeric thiol reagents

    Nektar Therapeutics · Granted Tue Dec 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  18. US 7851632

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Tue Dec 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  19. US 7851495

    Thiophene-carboxamides useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Tue Dec 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  20. US 7851194

    West Nile viruses with mutations in the 3′ terminal stem and loop secondary structure for use as live virus vaccines

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  21. US 7855214

    Fused cyclic systems useful as inhibitors of TEC family protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Tue Dec 21 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  22. US 7855220

    Bicyclic derivatives as modulators of voltage gated ion channels

    Vertex Pharmaceuticals Incorporated · Granted Tue Dec 21 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  23. US 7855233

    Citrate salt of Rasagiline

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Dec 21 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  24. US 7855291

    Process for the preparation of substituted phenylalanines

    LEXICON PHARMACEUTICALS, INC. · Granted Tue Dec 21 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  25. US 7855176

    Reduced volume formulation of glatiramer acetate and methods of administration

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Dec 21 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  26. US 7855076

    Use of discoidin domain receptor 1 (DDR1) and agents that affect the DDR1/collagen pathway

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 21 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  27. US 7855190

    Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration

    TEVA WOMEN'S HEALTH, INC. · Granted Tue Dec 21 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  28. US 7854932

    Immunogenic compositions comprising progastrin and uses thereof

    The Board of Regents of the University of Texas System · Granted Tue Dec 21 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  29. US 7855202

    Imidazopyridine derivatives as A2B adenosine receptor antagonists

    Laboratories Almirall, S.A. · Granted Tue Dec 21 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  30. US 7855221

    Crystalline form of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid

    Theravance, Inc. · Granted Tue Dec 21 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  31. US 7855276

    Framework residue substituted humanized COL-1 antibodies and their use

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 21 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  32. US 7855191

    Agent having a destructive effect on malignant tumors and method for the production thereof

    C.Y.L. Pharmazeutika GmbH · Granted Tue Dec 21 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  33. US 7858797

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Tue Dec 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  34. US 7858792

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Tue Dec 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  35. US 7858123

    Inorganic materials for hemostatic modulation and therapeutic wound healing

    The Regents of the University of California · Granted Tue Dec 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  36. US 7858592

    Interfering RNAs against the promoter region of P53

    The Board of Regents of the University of Texas System · Granted Tue Dec 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  37. US 7858349

    Anti-cancer compounds

    The Regents of the University of Colorado · Granted Tue Dec 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  38. US 7858583

    Process for purifying glycopeptide phosphonate derivatives

    Theravance, Inc. · Granted Tue Dec 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  39. US 7858605

    Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology

    TEVA WOMEN'S HEALTH, INC. · Granted Tue Dec 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  40. US 7858633

    Cycloalkyl substituted pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Tue Dec 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  41. US 7858635

    Spiro compounds as modulators of muscarinic receptors

    Vertex Pharmaceuticals Incorporated · Granted Tue Dec 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  42. US 7858749

    Polymer-factor VIII moiety conjugates

    Nektar Therapeutics · Granted Tue Dec 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  43. US 7858786

    Pyrimidines and pyrazines useful as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Tue Dec 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  44. US 7858790

    Modulators of muscarinic receptors

    Vertex Pharmaceuticals Incorporated · Granted Tue Dec 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  45. US 7858795

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Tue Dec 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  46. US 7858657

    Wortmannin analogs and methods of using same in combination with chemotherapeutic agents

    Arizona Board of Regents, Acting on Behalf of the University of Arizona · Granted Tue Dec 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  47. US 7863415

    Amino acid and peptide conjugates of amiloride and methods of use thereof

    The Regents of the University of California · Granted Tue Jan 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  48. US 7863421

    Polymer-factor VIII moiety conjugates

    Nektar Therapeutics · Granted Tue Jan 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many pharma patents expire in 2030?

880 published patents in our USPTO index have expiration dates falling in calendar year 2030.